Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

Self-identified gadolinium toxicity: comparison of gadolinium in bone and urine to healthy gadolinium-based contrast agent exposed volunteers.

Lord ML, McNeill FE, Gräfe JL, Noseworthy MD, Chettle DR.

Physiol Meas. 2018 Nov 28;39(11):115008. doi: 10.1088/1361-6579/aaedc6.

PMID:
30485255
2.

Observed Deposition of Gadolinium in Bone Using a New Noninvasive in Vivo Biomedical Device: Results of a Small Pilot Feasibility Study.

Lord ML, Chettle DR, Gräfe JL, Noseworthy MD, McNeill FE.

Radiology. 2018 Apr;287(1):96-103. doi: 10.1148/radiol.2017171161. Epub 2017 Dec 13.

PMID:
29237148
3.

The decrease in population bone lead levels in Canada between 1993 and 2010 as assessed by in vivo XRF.

McNeill FE, Fisher M, Chettle DR, Inskip M, Healey N, Bray R, Webber CE, Manton WI, Marro L, Arbuckle TE.

Physiol Meas. 2017 Dec 28;39(1):015005. doi: 10.1088/1361-6579/aa904f.

PMID:
28967867
4.

Coherent normalization for in vivo measurements of gadolinium in bone.

Keldani Z, Lord ML, McNeill FE, Chettle DR, Gräfe JL.

Physiol Meas. 2017 Sep 21;38(10):1848-1858. doi: 10.1088/1361-6579/aa87f0.

PMID:
28832339
5.

Performance comparison of two Olympus InnovX handheld x-ray analyzers for feasibility of measuring arsenic in skin in vivo - Alpha and Delta models.

Desouza ED, Gherase MR, Fleming DE, Chettle DR, O'Meara JM, McNeill FE.

Appl Radiat Isot. 2017 May;123:82-93. doi: 10.1016/j.apradiso.2017.02.029. Epub 2017 Feb 20.

PMID:
28260610
6.

Age and sex influence on bone and blood lead concentrations in a cohort of the general population living in Toronto.

Behinaein S, Chettle DR, Fisher M, Manton WI, Marro L, Fleming DE, Healey N, Inskip M, Arbuckle TE, McNeill FE.

Physiol Meas. 2017 Mar;38(3):431-451. doi: 10.1088/1361-6579/aa57b9. Epub 2017 Jan 9.

PMID:
28067216
7.

Confirming improved detection of gadolinium in bone using in vivo XRF.

Lord ML, McNeill FE, Gräfe JL, Galusha AL, Parsons PJ, Noseworthy MD, Howard L, Chettle DR.

Appl Radiat Isot. 2017 Feb;120:111-118. doi: 10.1016/j.apradiso.2016.12.011. Epub 2016 Dec 11.

PMID:
27987464
8.

In vivo neutron activation study of the short-term kinetic behaviour of sodium and chlorine in the human hand.

Mohseni HK, Cowan D, Chettle DR, Priest ND, Atanackovic J, Byun SH, Prestwich WV.

Physiol Meas. 2016 Nov;37(11):N76-N83. Epub 2016 Oct 6.

PMID:
27710928
9.

Optimization of data analysis for the in vivo neutron activation analysis of aluminum in bone.

Mohseni HK, Matysiak W, Chettle DR, Byun SH, Priest N, Atanackovic J, Prestwich WV.

Appl Radiat Isot. 2016 Oct;116:34-40. doi: 10.1016/j.apradiso.2016.07.004. Epub 2016 Jul 9.

PMID:
27474904
10.

A Pilot Study Measuring Aluminum in Bone in Alzheimer's Disease and control Subjects Using in vivo Neutron Activation Analysis.

Mohseni HK, Cowan D, Chettle DR, Milić AP, Priest N, Matysiak W, Atanackovic J, Byun SH, Prestwich WV.

J Alzheimers Dis. 2016 Jun 18;53(3):933-42. doi: 10.3233/JAD-160194.

PMID:
27340850
11.

A phantom-based feasibility study for detection of gadolinium in bone in-vivo using X-ray fluorescence.

Lord ML, McNeill FE, Gräfe JL, Noseworthy MD, Chettle DR.

Appl Radiat Isot. 2016 Jun;112:103-9. doi: 10.1016/j.apradiso.2016.03.021. Epub 2016 Mar 21.

PMID:
27019028
12.

Modeling elemental strontium in human bone based on in vivo x-ray fluorescence measurements in osteoporotic females self-supplementing with strontium citrate.

Moise H, Chettle DR, Pejović-Milić A.

Physiol Meas. 2016 Mar;37(3):429-41. doi: 10.1088/0967-3334/37/3/429. Epub 2016 Feb 24.

PMID:
26910208
13.

A History of In Vivo Neutron Activation Analysis in Measurement of Aluminum in Human Subjects.

Mohseni HK, Chettle DR.

J Alzheimers Dis. 2016;50(4):913-26. doi: 10.3233/JAD-150595. Review.

PMID:
26890739
14.

Development of a (170)Tm source for mercury monitoring studies in humans using XRF.

Timmaraju KP, Fajurally BN, Armstrong AF, Chettle DR.

Appl Radiat Isot. 2016 Apr;110:70-73. doi: 10.1016/j.apradiso.2015.12.066. Epub 2016 Jan 1.

PMID:
26773819
15.

Feasibility of measuring arsenic and selenium in human skin using in vivo x-ray fluorescence (XRF)--a comparison of methods.

Shehab H, Desouza ED, O'Meara J, Pejović-Milić A, Chettle DR, Fleming DE, McNeill FE.

Physiol Meas. 2016 Jan;37(1):145-61. doi: 10.1088/0967-3334/37/1/145. Epub 2015 Dec 18.

PMID:
26683849
16.

Physiologically based modeling of lead kinetics: a pilot study using data from a Canadian population.

MacMillan JW, Behinaein S, Chettle DR, Inskip M, McNeill FE, Manton WI, Healey N, Fisher M, Arbuckle TE, Fleming DE.

Environ Sci Process Impacts. 2015 Dec;17(12):2122-33. doi: 10.1039/c5em00517e.

PMID:
26565959
17.

Identification of oxygen-19 during in vivo neutron activation analysis of water phantoms.

Tahir SN, Chettle DR.

Physiol Meas. 2015 Dec;36(12):N127-34. doi: 10.1088/0967-3334/36/12/N127. Epub 2015 Oct 26.

PMID:
26502270
18.

Feasibility of measuring selenium in humans using in vivo neutron activation analysis.

Tahir SN, Chettle DR, Byun SH, Prestwich WV.

Physiol Meas. 2015 Nov;36(11):2217-30. doi: 10.1088/0967-3334/36/11/2217. Epub 2015 Sep 22.

PMID:
26393663
19.

Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women.

Wong AK, Beattie KA, Bhargava A, Cheung M, Webber CE, Chettle DR, Papaioannou A, Adachi JD; Canadian Multicentre Osteoporosis Study (CaMos) Research Group.

Bone. 2015 Oct;79:58-64. doi: 10.1016/j.bone.2015.05.010. Epub 2015 May 15.

20.

Measurements of fluorine in contemporary urban Canadians: a comparison of the levels found in human bone using in vivo and ex vivo neutron activation analysis.

Mostafaei F, McNeill FE, Chettle DR, Wainman BC, Pidruczny AE, Prestwich WV.

Physiol Meas. 2015 Mar;36(3):465-87. doi: 10.1088/0967-3334/36/3/465. Epub 2015 Feb 11.

PMID:
25669130
21.

A feasibility study to determine the potential of in vivo detection of gadolinium by x-ray fluorescence (XRF) following gadolinium-based contrast-enhanced MRI.

Mostafaei F, McNeill FE, Chettle DR, Noseworthy MD.

Physiol Meas. 2015 Jan;36(1):N1-13. doi: 10.1088/0967-3334/36/1/N1. Epub 2014 Dec 11.

PMID:
25501799
22.

Factors influencing uncertainties of in vivo bone lead measurement using a (109)Cd K X-ray fluorescence clover leaf geometry detector system.

Behinaein S, Chettle DR, Marro L, Malowany M, Fisher M, Fleming DE, Healey N, Inskip M, Arbuckle TE, McNeill FE.

Environ Sci Process Impacts. 2014 Dec;16(12):2742-51. doi: 10.1039/c4em00446a.

PMID:
25322174
23.

A neutron activation technique for manganese measurements in humans.

Bhatia C, Byun SH, Chettle DR, Inskip MJ, Prestwich WV.

J Trace Elem Med Biol. 2015;31:204-8. doi: 10.1016/j.jtemb.2014.07.018. Epub 2014 Aug 12.

PMID:
25169978
24.

Gadolinium detection via in vivo prompt gamma neutron activation analysis following gadolinium-based contrast agent injection: a pilot study in 10 human participants.

Gräfe JL, McNeill FE, Noseworthy MD, Chettle DR.

Physiol Meas. 2014 Sep;35(9):1861-72. doi: 10.1088/0967-3334/35/9/1861. Epub 2014 Aug 26.

PMID:
25154504
25.

The estimation of the rates of lead exchange between body compartments of smelter employees.

Behinaein S, Chettle DR, Egden LM, McNeill FE, Norman G, Richard N, Stever S.

Environ Sci Process Impacts. 2014 Jul;16(7):1705-15. doi: 10.1039/c4em00032c.

PMID:
24810478
26.

Monitoring bone strontium intake in osteoporotic females self-supplementing with strontium citrate with a novel in-vivo X-ray fluorescence based diagnostic tool.

Moise H, Chettle DR, Pejović-Milić A.

Bone. 2014 Apr;61:48-54. doi: 10.1016/j.bone.2014.01.002. Epub 2014 Jan 14.

PMID:
24434614
27.

Improvements in an in vivo neutron activation analysis (NAA) method for the measurement of fluorine in human bone.

Mostafaei F, McNeill FE, Chettle DR, Prestwich WV.

Physiol Meas. 2013 Oct;34(10):1329-41. doi: 10.1088/0967-3334/34/10/1329. Epub 2013 Sep 18.

PMID:
24045335
28.

Design of a phantom equivalent to measure bone-fluorine in a human's hand via delayed neutron activation analysis.

Mostafaei F, McNeill FE, Chettle DR, Prestwich WV, Inskip M.

Physiol Meas. 2013 May;34(5):503-12. doi: 10.1088/0967-3334/34/5/503. Epub 2013 Apr 15.

PMID:
23587669
29.

Nonlinearity in the relationship between bone lead concentrations and CBLI for lead smelter employees.

Behinaein S, Chettle DR, Egden LM, McNeill FE, Norman G, Richard N, Stever S.

J Environ Monit. 2012 Dec;14(12):3267-75. doi: 10.1039/c2em30652b. Epub 2012 Nov 14.

PMID:
23152131
30.

Accumulation of bone strontium measured by in vivo XRF in rats supplemented with strontium citrate and strontium ranelate.

Wohl GR, Chettle DR, Pejović-Milić A, Druchok C, Webber CE, Adachi JD, Beattie KA.

Bone. 2013 Jan;52(1):63-9. doi: 10.1016/j.bone.2012.09.002. Epub 2012 Sep 17.

PMID:
22995463
31.

Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: a case study.

Moise H, Adachi JD, Chettle DR, Pejović-Milić A.

Bone. 2012 Jul;51(1):93-7. doi: 10.1016/j.bone.2012.04.008. Epub 2012 Apr 23.

PMID:
22549020
32.

In vivo quantification of bone-fluorine by delayed neutron activation analysis: a pilot study of hand-bone-fluorine levels in a Canadian population.

Chamberlain M, Gräfe JL, Aslam, Byun SH, Chettle DR, Egden LM, Webber CE, McNeill FE.

Physiol Meas. 2012 Mar;33(3):375-84. doi: 10.1088/0967-3334/33/3/375. Epub 2012 Feb 28.

PMID:
22369953
33.

Ex vivo evaluation of a coherent normalization procedure to quantify in vivo finger strontium XRS measurements.

Heirwegh CM, Chettle DR, Pejovicc-Milicc A.

Med Phys. 2012 Feb;39(2):832-41. doi: 10.1118/1.3673787.

PMID:
22320793
34.

The feasibility of in vivo quantification of bone-fluorine in humans by delayed neutron activation analysis: a pilot study.

Chamberlain M, Gräfe JL, Byun SH, Chettle DR, Egden LM, Orchard GM, Webber CE, McNeill FE.

Physiol Meas. 2012 Feb;33(2):243-57. doi: 10.1088/0967-3334/33/2/243. Epub 2012 Jan 25.

PMID:
22273740
35.

Blood lead levels and cumulative blood lead index (CBLI) as predictors of late neurodevelopment in lead poisoned children.

Nie LH, Wright RO, Bellinger DC, Hussain J, Amarasiriwardena C, Chettle DR, Pejović-Milić A, Woolf A, Shannon M.

Biomarkers. 2011 Sep;16(6):517-24. doi: 10.3109/1354750X.2011.604133. Epub 2011 Aug 9.

36.

In vivo measurement of lead in the bones of smelter workers using the four-element 'clover-leaf' geometry detector system.

Behinaein S, Chettle DR, Atanackovic J, Egden LM, Fleming DE, Nie LH, Richard N, Stever S.

Phys Med Biol. 2011 Feb 7;56(3):653-65. doi: 10.1088/0031-9155/56/3/008. Epub 2011 Jan 10.

PMID:
21220841
37.

The feasibility of in vivo detection of gadolinium by prompt gamma neutron activation analysis following gadolinium-based contrast-enhanced MRI.

Gräfe JL, McNeill FE, Byun SH, Chettle DR, Noseworthy MD.

Appl Radiat Isot. 2011 Jan;69(1):105-11. doi: 10.1016/j.apradiso.2010.07.023. Epub 2010 Aug 5.

PMID:
20727776
38.

Evaluation of imaging technologies to correct for photon attenuation in the overlying tissue for in vivo bone strontium measurements.

Heirwegh CM, Chettle DR, Pejović-Milić A.

Phys Med Biol. 2010 Feb 21;55(4):1083-98. doi: 10.1088/0031-9155/55/4/012. Epub 2010 Jan 28.

PMID:
20107249
39.

Bone manganese as a biomarker of manganese exposure: a feasibility study.

Pejović-Milić A; Aslam, Chettle DR, Oudyk J, Pysklywec MW, Haines T.

Am J Ind Med. 2009 Oct;52(10):742-50. doi: 10.1002/ajim.20737.

PMID:
19753565
40.

Noninvasive measurement of aluminium in human bone: preliminary human study and improved system performance.

Aslam, Davis K, Pejović-Milić A, Chettle DR.

J Inorg Biochem. 2009 Nov;103(11):1585-90. doi: 10.1016/j.jinorgbio.2009.07.021. Epub 2009 Aug 15.

PMID:
19740544
41.

Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: weighted least-squares regression with different weighting functions.

de Brito JA, Chettle DR.

Phys Med Biol. 2009 Jul 7;54(13):L45-50. doi: 10.1088/0031-9155/54/13/L01. Epub 2009 Jun 12.

PMID:
19521005
42.

Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: the guiding role of the assumptions for least-squares regression in practical problem solving.

de Brito JA, de Carvalho ML, Chettle DR.

Phys Med Biol. 2009 Feb 21;54(4):919-34. doi: 10.1088/0031-9155/54/4/007. Epub 2009 Jan 14.

PMID:
19141884
43.

In vivo measurement of bone aluminum in population living in southern Ontario, Canada.

Davis K, Aslam, Pejović-Milić A, Chettle DR.

Med Phys. 2008 Nov;35(11):5115-23.

PMID:
19070246
44.

Opportunities to improve the in vivo measurement of manganese in human hands.

Aslam, Chettle DR, Pejović-Milić A, Waker AJ.

Phys Med Biol. 2009 Jan 7;54(1):17-28. doi: 10.1088/0031-9155/54/1/002. Epub 2008 Dec 5.

PMID:
19060358
45.

Lead post-mortem intake in human bones of ancient populations by (109)Cd-based X-ray fluorescence and EDXRF.

Rebôcho J, Carvalho ML, Marques AF, Ferreira FR, Chettle DR.

Talanta. 2006 Dec 15;70(5):957-61. doi: 10.1016/j.talanta.2006.05.062. Epub 2006 Jun 30.

PMID:
18970866
46.

Quantification of manganese in human hand bones: a feasibility study.

Aslam, Pejović-Milić A, Chettle DR, McNeill FE.

Phys Med Biol. 2008 Aug 7;53(15):4081-92.

PMID:
18782941
47.

A preliminary study for non-invasive quantification of manganese in human hand bones.

Aslam, Pejović-Milić A, Chettle DR, McNeill FE, Pysklywec MW, Oudyk J.

Phys Med Biol. 2008 Oct 7;53(19):N371-6. doi: 10.1088/0031-9155/53/19/N02. Epub 2008 Sep 2.

PMID:
18765892
48.

Coherent normalization of finger strontium XRF measurements: feasibility and limitations.

Zamburlini M, Pejović-Milić A, Chettle DR.

Phys Med Biol. 2008 Aug 7;53(15):N307-13. doi: 10.1088/0031-9155/53/15/N02. Epub 2008 Jul 17.

PMID:
18635898
49.

In vivo assessment of magnesium status in human body using accelerator-based neutron activation measurement of hands: a pilot study.

Aslam, Pejović-Milić A, McNeill FE, Byun SH, Prestwich WV, Chettle DR.

Med Phys. 2008 Feb;35(2):608-16.

PMID:
18383682
50.

Uncertainties in the relationship between tibia lead and cumulative blood lead index.

Healey N, Chettle DR, McNeill FE, Fleming DE.

Environ Health Perspect. 2008 Mar;116(3):A109; author reply A109-110. doi: 10.1289/ehp.10778. No abstract available.

Supplemental Content

Loading ...
Support Center